Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE)

NCT07150195 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.

NCT NCT07150195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07150195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE)
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
December 31, 2026
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhoses, liver, hepatic encephalopathy (he)